0000950170-23-034397.txt : 20230725 0000950170-23-034397.hdr.sgml : 20230725 20230725160130 ACCESSION NUMBER: 0000950170-23-034397 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230724 FILED AS OF DATE: 20230725 DATE AS OF CHANGE: 20230725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morningside Venture Investments Ltd CENTRAL INDEX KEY: 0001543112 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39894 FILM NUMBER: 231108536 BUSINESS ADDRESS: STREET 1: MCCARTHY LEGAL SERVICES STREET 2: 1188 CENTRE STREET CITY: NEWTON CENTRE STATE: MA ZIP: 02459 BUSINESS PHONE: 617-244-2800 MAIL ADDRESS: STREET 1: MCCARTHY LEGAL SERVICES STREET 2: 1188 CENTRE STREET CITY: NEWTON CENTRE STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GreenLight Biosciences Holdings, PBC CENTRAL INDEX KEY: 0001822691 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851914700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: (617) 616-8188 MAIL ADDRESS: STREET 1: 29 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: Environmental Impact Acquisition Corp DATE OF NAME CHANGE: 20200826 4 1 ownership.xml 4 X0508 4 2023-07-24 0001822691 GreenLight Biosciences Holdings, PBC GRNA 0001543112 Morningside Venture Investments Ltd 2ND FLOOR, LE PRINCE DE GALLES 3-5 AVENUE DES CITRONNIERS MONACO O9 MC 98000 MONACO false false true false false Common Stock 2023-07-24 4 J false 16919155 D 0 D Consists of 15,919,155 shares of common stock held directly by Morningside Venture Investments Limited and 1,000,000 shares of common stock held by MVIL, LLC, its wholly owned subsidiary. In connection with the merger of the Issuer with a wholly owned subsidiary of SW ParentCo, Inc. ("Parent"), the Reporting Persons entered into a Contribution and Exchange Agreement pursuant to which, on July 21, 2023, they contributed all of their shares of the Issuer's common stock to Parent in exchange for shares of preferred stock of Parent. /s/Frances Anne Elizabeth Richard, Director 2023-07-25